Connect Biopharma Holdings Ltd. (CNTB)
0.694
-0.06
(-7.50%)
USD |
NASDAQ |
Nov 10, 16:00
0.694
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Cash from Operations (Annual) : -51.21M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -51.21M |
| December 31, 2024 | -23.61M |
| December 31, 2023 | -47.74M |
| December 31, 2022 | -100.93M |
| Date | Value |
|---|---|
| December 31, 2021 | -84.49M |
| December 31, 2020 | -24.22M |
| December 31, 2019 | -13.06M |
| December 31, 2018 | -10.43M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anavex Life Sciences Corp. | -39.04M |
| Vaxcyte, Inc. | -655.58M |
| Foghorn Therapeutics, Inc. | -86.10M |
| Caribou Biosciences, Inc. | -110.99M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |